What Is HPLC Purity in Peptides? A Research Buyer’s Guide | QSC
QSC RESEARCH GUIDE
What Is HPLC Purity in Peptides? A Research Buyer’s Guide
HPLC (High Performance Liquid Chromatography) purity is the primary analytical measure of peptide quality. When a supplier states “≥99% HPLC purity,” they are claiming that at least 99% of the total UV-absorbing material in the vial is the target peptide. Understanding what HPLC measures — and what it does not — is essential for evaluating peptide quality claims and designing reliable research.
What HPLC Measures
What HPLC detects
What HPLC does NOT detect
Peptide chain length distribution (correct MW peaks vs deletion sequences)
Peptide biological activity (HPLC measures chemical purity, not potency)
What “≥99% HPLC” actually means
In RP-HPLC (reversed-phase HPLC), the peptide is separated by hydrophobicity on a C18 column. The peak area percentage at UV 214nm (amide bond absorbance) represents the fraction of total UV-absorbing material that is the target compound. ≥99% means impurity peaks represent <1% of total UV signal. This is the gold standard for peptide research use.
HPLC vs Mass Spectrometry — Why Both Matter
Test
What it confirms
Required for research?
RP-HPLC purity
% target peptide by UV absorbance — chemical purity
Why MS identity confirmation is as important as HPLC purity
A vial can be 99% HPLC pure but contain the wrong peptide — if synthesis produced a deletion sequence or scrambled sequence at high yield, HPLC would show high purity. MS identity confirmation (expected vs observed MW within ≤1 Da) verifies the compound is what was ordered. QSC provides both HPLC % and MS MW confirmation on every Janoshik COA.
Understanding QSC’s Janoshik COA
Every QSC batch is tested by Janoshik Analytical — an independent third-party laboratory. The COA confirms:
COA field
What it confirms
HPLC purity %
Reversed-phase HPLC at 214nm — primary purity measure
Observed MW (MS)
ESI-MS or MALDI — molecular weight within ≤1 Da of theoretical
Theoretical MW
Expected MW for the peptide sequence — baseline for MS comparison
Batch number
Traceability — each batch independently tested
Testing date
QC timeline — verifies recent testing
Why independent COA matters vs in-house QC
In-house quality testing has a conflict of interest — the supplier tests their own product. Independent third-party testing (Janoshik) eliminates this bias. The COA is issued by Janoshik directly and is publicly verifiable. This is the standard that distinguishes research-grade suppliers from unverified sources.
⚠️
Red Flags in Peptide Quality Claims
Claim
What to check
“>98% HPLC purity”
Industry minimum — acceptable, but ≥99% is the research standard. Ask which chromatography method.
Not defined for research peptides — marketing language. Ask for HPLC + MS data.
“tested by third party”
Which lab? Ask for the actual COA document, not a summary.
“free of impurities”
Vague — all peptides have some impurity level. The number is what matters: ≥99% is research standard.
❓
Frequently Asked Questions
What does ≥99% HPLC purity mean for a peptide?
In RP-HPLC, ≥99% means at least 99% of UV-absorbing material in the sample is the target compound. Impurity peaks (deletion sequences, oxidation products, aggregates) represent less than 1% of total UV signal. This is the research-grade standard.
Why do I need mass spectrometry confirmation in addition to HPLC purity?
HPLC purity tells you what fraction is the dominant compound. MS identity tells you whether that dominant compound is actually the peptide you ordered. Both are needed: high HPLC purity + correct MS MW = verified research-grade quality.
What is a Janoshik COA and why does QSC use it?
Janoshik Analytical is an independent third-party testing laboratory that issues certificates of analysis for peptide suppliers. QSC sends every batch to Janoshik for HPLC purity and MS identity testing. The resulting COA is issued by Janoshik independently — not by QSC — providing unbiased quality verification.
Can a peptide be 99% pure but not work in research?
Yes — purity measures chemical composition, not biological activity. A peptide could be structurally correct (high HPLC purity, correct MS) but improperly folded, oxidised at a key residue, or lack the expected receptor binding properties for other reasons. For confirmed activity, functional assay data from published literature on the specific compound is the reference.
